Dimensional Fund Advisors’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Buy
531,267
+304,110
+134% +$1.8M ﹤0.01% 2637
2025
Q4
$1.21M Buy
227,157
+179,449
+376% +$998K ﹤0.01% 2835
2025
Q3
$208K Sell
47,708
-37,595
-44% -$122K ﹤0.01% 3113
2025
Q2
$258K Buy
85,303
+15,700
+23% +$54.2K ﹤0.01% 3082
2025
Q1
$297K Buy
69,603
+48,606
+231% +$217K ﹤0.01% 3080
2024
Q4
$111K Buy
+20,997
New +$67.8K ﹤0.01% 3232
2024
Q2
Sell
-12,126
Closed -$48.6K 3406
2024
Q1
$48.6K Buy
+12,126
New +$39.1K ﹤0.01% 3333
2023
Q4
Sell
-13,821
Closed -$23.1K 3453
2023
Q3
$23.1K Sell
13,821
-4,931
-26% -$11.3K ﹤0.01% 3436
2023
Q2
$44.8K Buy
18,752
+1,918
+11% +$5.7K ﹤0.01% 3415
2023
Q1
$52.2K Hold
16,834
﹤0.01% 3380
2022
Q4
$45 Buy
16,834
+1,052
+7% +$3.32K ﹤0.01% 3401
2022
Q3
$47K Sell
15,782
-12,918
-45% -$43.8K ﹤0.01% 3411
2022
Q2
$84K Sell
28,700
-1,906
-6% -$6.97K ﹤0.01% 3349
2022
Q1
$156K Sell
30,606
-2,868
-9% -$15.1K ﹤0.01% 3341
2021
Q4
$226K Buy
+33,474
New +$231K ﹤0.01% 3326
2018
Q3
Sell
-464
Closed -$45K 3437
2018
Q2
$45K Hold
464
﹤0.01% 3341
2018
Q1
$46K Hold
464
﹤0.01% 3316
2017
Q4
$35K Hold
464
﹤0.01% 3310
2017
Q3
$37K Buy
+464
New +$26.5K ﹤0.01% 3312

Other funds holding TARA

Dimensional Fund Advisors's TARA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Protara Therapeutics (TARA) stake by 134% in Q1 2026, buying an estimated $1.8M and bringing the position to 531,267 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Dimensional Fund Advisors first reported a position in TARA in Q3 2017 and has held it in 19 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Dimensional Fund Advisors held 531,267 shares of Protara Therapeutics worth $2.77M as of Q1 2026.
  • Dimensional Fund Advisors bought 304,110 Protara Therapeutics shares in Q1 2026, an estimated $1.8M.
  • Protara Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2637 holding.
  • Dimensional Fund Advisors first reported a position in Protara Therapeutics in Q3 2017 and has held it in 19 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.